citalopram and pexacerfont

citalopram has been researched along with pexacerfont in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coric, V; D'Souza, BB; Delmonte, T; Dockens, RC; Emison, E; Feldman, HH; Gentile, KA; Goddard, AW; Grebb, JA; Huang, SP; Oren, DA; Pultz, J; Shekhar, A; Stock, EG; Wu, X; Zimbroff, DL	1

Trials

1 trial(s) available for citalopram and pexacerfont

Article	Year
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depression and anxiety, 2010, Volume: 27, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Psychometrics; Pyrazoles; Receptors, Corticotropin-Releasing Hormone; Severity of Illness Index; Triazines; Young Adult	2010

Article

Year

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.

Depression and anxiety, 2010, Volume: 27, Issue:5

Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Psychometrics; Pyrazoles; Receptors, Corticotropin-Releasing Hormone; Severity of Illness Index; Triazines; Young Adult

2010